Ballicules.com

Succimer

CHEMET

What it isOral dithiol chelator for lead poisoning in children with blood lead levels above 45 mcg/dL.

Why this oneAllows outpatient oral chelation for moderate lead poisoning and causes less essential-metal loss than calcium disodium EDTA.

What limits itIt does not cross the blood-brain barrier or treat lead encephalopathy; remove the exposure source and monitor for rebound lead levels, neutropenia, and transaminitis.

FDA label

FDA dosingPopulationStartTargetMax
Lead poisoningPediatric10 mg/kg or 350 mg/m² q8h (TID) ×5 daysthen 10 mg/kg or 350 mg/m² q12h (BID) ×14 days

Renal Assess renal function (BUN/creatinine/urinary protein) before treatment; succimer and lead are renally excreted.

Hepatic Monitor AST/ALT at baseline and weekly; reduce/interrupt if elevations >5× ULN.

Total 19-day course; minimum 2 weeks between repeat courses; dosing >3 weeks not established.

Instructions

Cautions

Adverse reactions

Pregnancy May cause fetal harm (animal data); use only if benefit justifies risk; use contraception during and 14 days after.

Lactation No data on presence in milk; women with blood lead ≥40 mcg/dL should not breastfeed.

NO BOXED WARNINGS

Principal riskneutropenia; monitor CBC and interrupt if ANC falls below 1,200/mcL

Cost, est. cash$50–$3,000/use

Generic entryNo US generic

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityAllergic, renal or procedure-related complications vary by diagnostic agent and route.

Mechanism of action: Succimer ballicule

Succimer ballicule: receptor binding, kinetics and half-life diagram

Open Succimer in the interactive console ↗